Overall Status

Completed (2)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

National Cancer Institute (NCI) (1)

Seagen Inc. (1)

University of Arizona (1)

Collaborator

Intervention

anti-cluster of differentiation (cd)19-chimeric antigen receptor (car) (1)

bendamustine (1)

cyclophosphamide (1)

sgn-30 (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (1)

NIH (1)

Other (1)

Study Type

Interventional (3)

large cell lymphoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)

Recruiting

Acute Lymphoblastic Leukemia
+12 more

Tucson, Arizona

The University of Arizona Cancer Center

Dec 13, 2022

ALL, B Cell Lymphoma, Leukemia Trial run by the NCI (Anti-Cluster of Differentiation (CD)19-Chimeric antigen receptor (CAR))

Completed

ALL
+4 more

Anti-Cluster of Differentiation (CD)19-Chimeric antigen receptor (CAR)

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Aug 14, 2020

Large Cell Lymphoma Trial in United States (SGN-30)

Completed

Large Cell Lymphoma

SGN-30

Birmingham, Alabama
+12 more

Dec 17, 2014